HEX

File: D:/hMailServer/Data/sarahharvey.com/bob/A5/{A5711E97-96AF-430B-BF76-53123B095E6C}.eml
From: "Investment Oracle" <offer@investmentoracle.co.uk>
To: "Robert Home" <bob@sarahharvey.com>
Subject: Tax Efficient Investment | Oncology testing kits with regulatory approval
Date: Fri, 10 Jul 2026 08:21:17 +0100
Message-ID: <ea365d1409496002f864b0ea632cf465@investmentoracle.co.uk>
MIME-Version: 1.0
Content-Type: multipart/alternative;
	boundary="----=_NextPart_000_13C9_01DD1BB6.61041C00"
Thread-Index: AQFih7boTN2wsNUUgY1wuIuAtHiQEw==

This is a multipart message in MIME format.

------=_NextPart_000_13C9_01DD1BB6.61041C00
Content-Type: text/plain;
	charset="utf-8"
Content-Transfer-Encoding: 8bit

  <https://eot.investmentoracle.co.uk/q/UxSsFWawcS3usLUufqCXEA~~/AAAHURA~/hUAjD4Tc_oJfGTHWwQj9fYVsv7Jc5y8QiWeOxFCQcagB5A3GL95-qd4APQST4T0bGyOWQH2TlmJyr4NS6H8FmA~~>
Early cancer detection can help save lives. This UK and European based 
laboratory is now set to grow worldwide ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌




 <https://eot.investmentoracle.co.uk/f/a/EQV6QwvSfc8m6Db_kp-qow~~/AAAHURA~/tCobR5y_rYswfQJP3W9QN4So9krNlVs4TA-Chl_0ExzkyuiK_aQkrPmDwNsrs3du2kxgeiJg68ixKpCKeQDbrphn2y6QlbkX5A-tMGMubZFcA9d6UO9hfbWfVV43Tk54lhrGHneRSYbIKsQ_H7sxNWA3Br6A4XX8xDTS8pl8yBv-BgR-C8IQLSnZcjEAKReW_YSJbBU_ErWaUu2egUSVYh-IlaS66qaDS_2mJkkf4g0~>







PIONEERING EARLY CANCER DETECTION & TAILORED TREATMENT PLANS



Invest from £12,000




At Frontier Diagnostics, we're not just developing new ways to detect 
cancer, we're changing the entire approach to how it's monitored, treated, 
and beaten. Led by industry-renowned biochemist Dr. Martin Burow, former 
Head of Asia Pacific at Thermo Fisher and a leading global authority on 
circulating tumour cell research, Frontier has built a precision diagnostics 
platform that gives oncologists real-time intelligence from a simple blood 
draw. No invasive biopsy. No waiting months for a scan. Just fast, accurate, 
personalised data - at the moment it matters most.



 <https://eot.investmentoracle.co.uk/f/a/EQV6QwvSfc8m6Db_kp-qow~~/AAAHURA~/tCobR5y_rYswfQJP3W9QN4So9krNlVs4TA-Chl_0ExzkyuiK_aQkrPmDwNsrs3du2kxgeiJg68ixKpCKeQDbrphn2y6QlbkX5A-tMGMubZFcA9d6UO9hfbWfVV43Tk54lhrGHneRSYbIKsQ_H7sxNWA3Br6A4XX8xDTS8pl8yBv-BgR-C8IQLSnZcjEAKReW_YSJbBU_ErWaUu2egUSVYh-IlaS66qaDS_2mJkkf4g0~>

HMRC Approved EIS



 <https://eot.investmentoracle.co.uk/f/a/EQV6QwvSfc8m6Db_kp-qow~~/AAAHURA~/tCobR5y_rYswfQJP3W9QN4So9krNlVs4TA-Chl_0ExzkyuiK_aQkrPmDwNsrs3du2kxgeiJg68ixKpCKeQDbrphn2y6QlbkX5A-tMGMubZFcA9d6UO9hfbWfVV43Tk54lhrGHneRSYbIKsQ_H7sxNWA3Br6A4XX8xDTS8pl8yBv-BgR-C8IQLSnZcjEAKReW_YSJbBU_ErWaUu2egUSVYh-IlaS66qaDS_2mJkkf4g0~>

10.5× Projected Returns


 <https://eot.investmentoracle.co.uk/f/a/EQV6QwvSfc8m6Db_kp-qow~~/AAAHURA~/tCobR5y_rYswfQJP3W9QN4So9krNlVs4TA-Chl_0ExzkyuiK_aQkrPmDwNsrs3du2kxgeiJg68ixKpCKeQDbrphn2y6QlbkX5A-tMGMubZFcA9d6UO9hfbWfVV43Tk54lhrGHneRSYbIKsQ_H7sxNWA3Br6A4XX8xDTS8pl8yBv-BgR-C8IQLSnZcjEAKReW_YSJbBU_ErWaUu2egUSVYh-IlaS66qaDS_2mJkkf4g0~>

Exit Targeted Q4 2029




"WE ARE NOT JUST IMPROVING DIAGNOSTICS - WE ARE REWRITING THE TIMELINE OF 
CANCER CARE"




Dr. Martin Burow, CEO



ACCESS THE INVESTMENT DETAILS 
<https://eot.investmentoracle.co.uk/f/a/EQV6QwvSfc8m6Db_kp-qow~~/AAAHURA~/tCobR5y_rYswfQJP3W9QN4So9krNlVs4TA-Chl_0ExzkyuiK_aQkrPmDwNsrs3du2kxgeiJg68ixKpCKeQDbrphn2y6QlbkX5A-tMGMubZFcA9d6UO9hfbWfVV43Tk54lhrGHneRSYbIKsQ_H7sxNWA3Br6A4XX8xDTS8pl8yBv-BgR-C8IQLSnZcjEAKReW_YSJbBU_ErWaUu2egUSVYh-IlaS66qaDS_2mJkkf4g0~>


 INVESTMENT HIGHLIGHTS




*	HMRC-approved EIS opportunity offering generous tax breaks
*	Shares priced at £1.20. Post-money valuation: £18m
*	Raising £3m. Minimum investment: £12,000
*	ISO 15189-accredited laboratory. Operational in UK & Europe
*	Established distribution partnerships across Southeast Asia
*	Forecast £61.75m revenue and £31.5m EBITDA by 2029
*	Planned M&A exit Q4 2029. Targeting 10.5x return




WHY INVEST


*	A £1.87bn European cancer diagnostics market growing at 4.8% annually
*	Proprietary CTC technology with a clear, scalable path to global clinical 
adoption
*	Already operating in a clinical setting - ISO 15189-accredited lab 
processing real patient samples with a 5-day turnaround
*	Dual revenue model - per-test lab fees plus hardware sales of the Quantum 
FluoScope device, with recurring consumable income
*	Debt-free company backed by a world-class medical advisory board including 
former Chief Medical Officer of Teva Pharmaceuticals

ACCESS THE INVESTMENT DETAILS 
<https://eot.investmentoracle.co.uk/f/a/EQV6QwvSfc8m6Db_kp-qow~~/AAAHURA~/tCobR5y_rYswfQJP3W9QN4So9krNlVs4TA-Chl_0ExzkyuiK_aQkrPmDwNsrs3du2kxgeiJg68ixKpCKeQDbrphn2y6QlbkX5A-tMGMubZFcA9d6UO9hfbWfVV43Tk54lhrGHneRSYbIKsQ_H7sxNWA3Br6A4XX8xDTS8pl8yBv-BgR-C8IQLSnZcjEAKReW_YSJbBU_ErWaUu2egUSVYh-IlaS66qaDS_2mJkkf4g0~>



Disclaimer:
Any person accessing the email and considering potential investment 
opportunities featured in the email should make their own commercial 
assessment after seeking the advice of an appropriately authorised or 
regulated financial adviser. This email should not be construed as advice or 
a personal recommendation to any prospective investor. Investments of this 
nature carry risks to your capital and can go up or down. Past performance 
is not indicative of future results. This opportunity is only suitable for 
high net worth or self-sophisticated investors as defined below. You have an 
annual income in excess of £100K. Have net assets in excess of £250K 
(excluding your pension funds and assets and your private residence). You 
have been a Director of a company turning over at least £1 million within 
the last two years. You have made more than one investment in an unlisted 
company in the previous two years. You have been a member of a network or 
syndicate of business angels for at least six months. You have worked in the 
last two years in a professional capacity in the private equity sector or in 
the provision of finance for small and medium enterprises.

Whistler Close
Black Dam
Basingstoke
Hants
RG21 3HN
United Kingdom



Unsubscribe

Powered by EmailOctopus 
<https://eot.investmentoracle.co.uk/f/a/mAnvgsM3qE3BdtGnbfJiiw~~/AAAHURA~/caIJafCBG2GnLqBpAkWvQE5U-npmEIGPix9EfPbXvUWTZVKPMjN98gDJNePB4V0NHUl_uItKEjONFEjwdOASZIWpLZir90K0eFYR22blI101-iu87BoHiBOMBDD74fMNtFQT-QEHSBOapys_BZOP76rhatK5rEY0IuUCobde9ci9avCrAaliDDg0TH8XPWj_nxshpQSznOj4qA3CKi1GKFG2-1mnZzedr5oRc2bfXDcJS4cnAC1ADcX9-GloTFU1rTdfzY7qXiWnhp67VJzI830PoKT-7CxBczcAWRiApOyBTdAPAfqEZ8beyggGAquhV33-hnMUMTxFt9L4muX7tEzq_z0o2SDThqivL1ruwa4~>

  <https://eot.investmentoracle.co.uk/q/rkkcaVwSlonIgHypQY3gbQ~~/AAAHURA~/OkPbKeVfFQuhd13EhLCcyqDa1HzMPlCqaa-vSn7Jjc0njR7abFYXaZmFCMnU3-ID-XzCULRERR1KtkpgBxZvhw~~>

------=_NextPart_000_13C9_01DD1BB6.61041C00
Content-Type: text/html;
	boundary="d2QVdmPR";
	charset="utf-8"
Content-Transfer-Encoding: quoted-printable

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" =
"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"><html =
dir=3D"ltr" xmlns=3D"http://www.w3.org/1999/xhtml" =
xmlns:o=3D"urn:schemas-microsoft-com:office:office" =
lang=3D"en"><head><meta charset=3D"UTF-8"><meta =
content=3D"width=3Ddevice-width, initial-scale=3D1" =
name=3D"viewport"><meta =
name=3D"x-apple-disable-message-reformatting"><meta =
http-equiv=3D"X-UA-Compatible" content=3D"IE=3Dedge"><meta =
content=3D"telephone=3Dno" name=3D"format-detection"><title>I-429 - EIS =
- P-100 - CL48 - Sennid - BR1385 - MAY26</title> <!--[if (mso =
16)]><style type=3D"text/css">     a {text-decoration: none;}     =
</style><![endif]--><!--[if gte mso 9]><style>sup { font-size: 100% =
!important; }</style><![endif]--><!--[if gte mso 9]><noscript> <xml> =
<o:OfficeDocumentSettings> <o:AllowPNG></o:AllowPNG> =
<o:PixelsPerInch>96</o:PixelsPerInch> </o:OfficeDocumentSettings> </xml> =
</noscript>
<![endif]--><!--[if mso]><xml> <w:WordDocument =
xmlns:w=3D"urn:schemas-microsoft-com:office:word"> =
<w:DontUseAdvancedTypographyReadingMail/> </w:WordDocument> </xml>
<![endif]--><!--[if !mso]><!-- --><link =
href=3D"https://fonts.googleapis.com/css2?family=3DOswald:wght@500&displa=
y=3Dswap" rel=3D"stylesheet"><link =
href=3D"https://fonts.googleapis.com/css2?family=3DPoppins&family=3DWork+=
Sans&display=3Dswap" rel=3D"stylesheet"><link =
href=3D"https://fonts.googleapis.com/css2?family=3DWork+Sans" =
rel=3D"stylesheet"><!--<![endif]--><style =
type=3D"text/css">.rollover:hover .rollover-first { =
max-height:0px!important; display:none!important;}.rollover:hover =
.rollover-second { max-height:none!important; =
display:block!important;}.rollover span { font-size:0px;}u + .body img ~ =
div div { display:none;}#outlook a { =
padding:0;}span.MsoHyperlink,span.MsoHyperlinkFollowed { color:inherit; =
mso-style-priority:99;}a.e { mso-style-priority:100!important; =
text-decoration:none!important;}
 a[x-apple-data-detectors],#MessageViewBody a { color:inherit!important; =
text-decoration:none!important; font-size:inherit!important; =
font-family:inherit!important; font-weight:inherit!important; =
line-height:inherit!important;}.n { display:none; float:left; =
overflow:hidden; width:0; max-height:0; line-height:0; =
mso-hide:all;}@media only screen and (max-width:600px) {.bq { =
padding-right:0px!important } .bp { padding-bottom:20px!important } .bo =
{ padding-bottom:10px!important } .bn { padding:0px!important } .bm { =
padding-top:15px!important } .bl { padding-bottom:0px!important } .bk { =
padding-left:0px!important } *[class=3D"gmail-fix"] { =
display:none!important } p, a { line-height:150%!important } h1, h1 a { =
line-height:120%!important } h2, h2 a { line-height:120%!important } h3, =
h3 a { line-height:120%!important } h4, h4 a { =
line-height:120%!important } h5, h5 a { line-height:120%!important } h6, =
h6 a { line-height:120%!important }
 h1 { font-size:22px!important; text-align:center } h2 { =
font-size:22px!important; text-align:center } h3 { =
font-size:22px!important; text-align:center } h4 { =
font-size:24px!important; text-align:left } h5 { =
font-size:20px!important; text-align:left } h6 { =
font-size:16px!important; text-align:left } .bh p, .bh a { =
font-size:14px!important } .l, .l h1, .l h2, .l h3, .l h4, .l h5, .l h6 =
{ text-align:center!important } .i .rollover:hover .rollover-second, .l =
.rollover:hover .rollover-second, .k .rollover:hover .rollover-second { =
display:inline!important } a.e, button.e { display:block!important; =
font-size:14px!important; padding:10px 20px 10px 20px!important; =
line-height:120%!important } .bc { display:block!important } .v table, =
.w, .x { width:100%!important; border-collapse:separate!important } .s =
table, .t table, .u table, .s, .u, .t { width:100%!important; =
max-width:600px!important }
 .adapt-img { width:100%!important; height:auto!important } .p, .q { =
display:none!important } .h-auto { height:auto!important } a.e.g { =
padding:15px!important } a.e.f { padding:10px!important } a.e, button.e, =
label.e { padding-top:0px!important; padding-bottom:0px!important; =
padding-right:0px!important; padding-left:0px!important } .a .d, .a .d * =
{ font-size:24px!important } .a .c, .a .c * { font-size:16px!important } =
.a .b, .a .b * { font-size:20px!important } }@media screen and =
(max-width:384px) {.mail-message-content { width:414px!important } =
}</style>
 </head> <body data-new-gr-c-s-loaded=3D"9.72.0" class=3D"body" =
style=3D"width:100%;height:100%;font-family:arial, 'helvetica neue', =
helvetica, =
sans-serif;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%;paddin=
g:0;Margin:0">
<div =
style=3D"color:transparent;visibility:hidden;opacity:0;font-size:0px;bord=
er:0;max-height:1px;width:1px;margin:0px;padding:0px;border-width:0px!imp=
ortant;display:none!important;line-height:0px!important;"><img =
border=3D"0" width=3D"1" height=3D"1" =
src=3D"https://eot.investmentoracle.co.uk/q/UxSsFWawcS3usLUufqCXEA~~/AAAH=
URA~/hUAjD4Tc_oJfGTHWwQj9fYVsv7Jc5y8QiWeOxFCQcagB5A3GL95-qd4APQST4T0bGyOW=
QH2TlmJyr4NS6H8FmA~~" alt=3D""/></div>
<div style=3D"display: none; max-height: 0px; overflow: hidden;">Early =
cancer detection can help save lives. This UK and European based =
laboratory is now set to grow =
worldwide&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbs=
p;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&n=
bsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C=
&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C=
&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C=
&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=
=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=
=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=
=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=
=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=
=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;=E2=80=8C&nbsp;</div><div =
dir=3D"ltr" class=3D"es-wrapper-color" lang=3D"en" =
style=3D"background-color:#F6F6F6"><!--[if gte mso 9]><v:background =
xmlns:v=3D"urn:schemas-microsoft-com:vml" fill=3D"t"> <v:fill =
type=3D"tile" color=3D"#f6f6f6"></v:fill> =
</v:background><![endif]--><table width=3D"100%" cellspacing=3D"0" =
cellpadding=3D"0" class=3D"es-wrapper" role=3D"none" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px;padding:0;Margin:0;width:100%;height:100%;backgroun=
d-repeat:repeat;background-position:center top"><tr>
<td valign=3D"top" style=3D"padding:0;Margin:0"><table cellspacing=3D"0" =
cellpadding=3D"0" align=3D"center" class=3D"s" role=3D"none" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px;width:100%;table-layout:fixed !important"><tr><td =
align=3D"center" bgcolor=3D"#ffffff" =
style=3D"padding:0;Margin:0;background-color:#ffffff"><table =
cellspacing=3D"0" cellpadding=3D"0" bgcolor=3D"#ffffff" align=3D"center" =
class=3D"bh" role=3D"none" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px;background-color:#FFFFFF;width:600px"><tr><td =
align=3D"left" style=3D"padding:0;Margin:0"><table width=3D"100%" =
cellspacing=3D"0" cellpadding=3D"0" role=3D"none" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px"><tr>
<td valign=3D"top" align=3D"center" =
style=3D"padding:0;Margin:0;width:600px"><table width=3D"100%" =
cellspacing=3D"0" cellpadding=3D"0" role=3D"presentation" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px"><tr><td align=3D"center" =
style=3D"padding:0;Margin:0;font-size:0px"><a target=3D"_blank" =
href=3D"https://eot.investmentoracle.co.uk/f/a/EQV6QwvSfc8m6Db_kp-qow~~/A=
AAHURA~/tCobR5y_rYswfQJP3W9QN4So9krNlVs4TA-Chl_0ExzkyuiK_aQkrPmDwNsrs3du2=
kxgeiJg68ixKpCKeQDbrphn2y6QlbkX5A-tMGMubZFcA9d6UO9hfbWfVV43Tk54lhrGHneRSY=
bIKsQ_H7sxNWA3Br6A4XX8xDTS8pl8yBv-BgR-C8IQLSnZcjEAKReW_YSJbBU_ErWaUu2egUS=
VYh-IlaS66qaDS_2mJkkf4g0~" =
style=3D"mso-line-height-rule:exactly;text-decoration:underline;color:#2C=
B543;font-size:14px"><img =
src=3D"https://hhyqcw.stripocdn.email/content/guids/CABINET_bb89119e98324=
472b76ebb95026f5abd1ca9deaf45af5560d554f946c8168d2d/images/i_252_c15_cl_2=
0_frontier_diagnostic_march_12_p_xxx.png" alt=3D"" width=3D"600" =
class=3D"adapt-img" =
style=3D"display:block;font-size:14px;border:0;outline:none;text-decorati=
on:none;margin:0" height=3D"446"></a> =
</td></tr></table></td></tr></table></td></tr></table></td></tr></table>
 <table cellpadding=3D"0" cellspacing=3D"0" align=3D"center" class=3D"s" =
role=3D"none" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px;width:100%;table-layout:fixed !important"><tr><td =
align=3D"center" bgcolor=3D"#ffffff" =
style=3D"padding:0;Margin:0;background-color:#ffffff"><table =
bgcolor=3D"#3D3A39" align=3D"center" cellpadding=3D"0" cellspacing=3D"0" =
class=3D"bh" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px;background-color:#3d3a39;width:600px" =
role=3D"none"><tr><td align=3D"left" bgcolor=3D"#3d5974" =
style=3D"padding:0 20px;Margin:0;background-color:#3d5974"><table =
cellpadding=3D"0" cellspacing=3D"0" width=3D"100%" role=3D"none" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px"><tr>
<td align=3D"center" valign=3D"top" =
style=3D"padding:0;Margin:0;width:560px"><table cellpadding=3D"0" =
cellspacing=3D"0" width=3D"100%" role=3D"presentation" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px"><tr><td align=3D"center" bgcolor=3D"#3d5974" =
class=3D"a" style=3D"padding:5px 0 20px;Margin:0"><p class=3D"l" =
style=3D"Margin:0;mso-line-height-rule:exactly;font-family:oswald, =
sans-serif;line-height:13px;letter-spacing:0;color:#a9d1d6;font-size:11px=
"><br/> </p><p class=3D"l" =
style=3D"Margin:0;mso-line-height-rule:exactly;font-family:oswald, =
sans-serif;line-height:36px;letter-spacing:0;color:#a9d1d6;font-size:11px=
"><b style=3D"font-size:30px;line-height:36px"><strong =
style=3D"font-weight:700 !important">PIONEERING <span =
style=3D"color:#ffffff">EARLY CANCER DETECTION</span> &amp; TAILORED =
<span style=3D"color:#ffffff">TREATMENT PLANS</span></strong></b></p>
<p class=3D"l" =
style=3D"Margin:0;mso-line-height-rule:exactly;font-family:oswald, =
sans-serif;line-height:36px;letter-spacing:0;color:#a9d1d6;font-size:11px=
"><b style=3D"font-size:30px;line-height:36px"><strong =
style=3D"font-weight:700 =
!important;color:#ffffff">=E2=80=8B</strong></b></p><p class=3D"l d" =
style=3D"Margin:0;mso-line-height-rule:exactly;font-family:oswald, =
sans-serif;line-height:29px;letter-spacing:0;color:#ffffff;font-size:24px=
"><b style=3D"line-height:120%;color:#a9d1d6">Invest from</b><b =
style=3D"line-height:120%"> =C2=A312,000</b></p></td></tr> =
</table></td></tr></table></td></tr> <tr><td align=3D"left" =
style=3D"padding:0;Margin:0"><table cellpadding=3D"0" cellspacing=3D"0" =
width=3D"100%" role=3D"none" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px"><tr>
<td align=3D"left" style=3D"padding:0;Margin:0;width:600px"><table =
cellpadding=3D"0" cellspacing=3D"0" role=3D"presentation" width=3D"100%" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px"><tr>
<td align=3D"center" bgcolor=3D"#3d5974" class=3D"a" =
style=3D"Margin:0;padding:10px 35px 35px"><p =
style=3D"Margin:0;mso-line-height-rule:exactly;font-family:Poppins;line-h=
eight:21px;letter-spacing:0;color:#ffffff;font-size:14px">At Frontier =
Diagnostics, we're not just developing new ways to detect cancer, we're =
changing the entire approach to how it's monitored, treated, and beaten. =
Led by industry-renowned biochemist Dr. Martin Burow, former Head of =
Asia Pacific at Thermo Fisher and a leading global authority on =
circulating tumour cell research, Frontier has built a precision =
diagnostics platform that gives oncologists real-time intelligence from =
a simple blood draw. No invasive biopsy. No waiting months for a scan. =
Just fast, accurate, personalised data - at the moment it matters =
most.</p> </td></tr></table></td></tr></table></td></tr> <tr>
<td align=3D"left" bgcolor=3D"#3d5974" style=3D"padding:0 =
15px;Margin:0;background-color:#3d5974"><!--[if mso]><table =
style=3D"width:570px" cellpadding=3D"0" cellspacing=3D"0"><tr><td =
style=3D"width:198px" valign=3D"top"><![endif]--><table =
cellpadding=3D"0" cellspacing=3D"0" align=3D"left" class=3D"w" =
role=3D"none" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px;float:left"><tr><td align=3D"center" class=3D"bq =
bp" style=3D"padding:0;Margin:0;width:178px"><table cellpadding=3D"0" =
cellspacing=3D"0" width=3D"100%" role=3D"presentation" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px"><tr>
<td align=3D"center" style=3D"padding:0;Margin:0;font-size:0px"><a =
target=3D"_blank" =
href=3D"https://eot.investmentoracle.co.uk/f/a/EQV6QwvSfc8m6Db_kp-qow~~/A=
AAHURA~/tCobR5y_rYswfQJP3W9QN4So9krNlVs4TA-Chl_0ExzkyuiK_aQkrPmDwNsrs3du2=
kxgeiJg68ixKpCKeQDbrphn2y6QlbkX5A-tMGMubZFcA9d6UO9hfbWfVV43Tk54lhrGHneRSY=
bIKsQ_H7sxNWA3Br6A4XX8xDTS8pl8yBv-BgR-C8IQLSnZcjEAKReW_YSJbBU_ErWaUu2egUS=
VYh-IlaS66qaDS_2mJkkf4g0~" =
style=3D"mso-line-height-rule:exactly;text-decoration:underline;color:#2C=
B543;font-size:14px"><img =
src=3D"https://hhyqcw.stripocdn.email/content/guids/CABINET_bb89119e98324=
472b76ebb95026f5abd1ca9deaf45af5560d554f946c8168d2d/images/i252_eis_cl20_=
frontier_diagnostic_mar_25_p005.png" alt=3D"" width=3D"178" =
class=3D"adapt-img" =
style=3D"display:block;font-size:14px;border:0;outline:none;text-decorati=
on:none;margin:0" height=3D"134"></a> </td></tr><tr><td align=3D"center" =
valign=3D"top" height=3D"16" class=3D"h-auto" style=3D"padding:10px 0 =
25px;Margin:0"><p =
style=3D"Margin:0;mso-line-height-rule:exactly;font-family:poppins;line-h=
eight:17px;letter-spacing:0;color:#ffffff;font-size:14px"><strong =
style=3D"font-weight:700 !important">HMRC Approved =
EIS</strong></p></td></tr></table></td>
<td class=3D"q" =
style=3D"padding:0;Margin:0;width:20px"></td></tr></table> <!--[if =
mso]></td> <td style=3D"width:177px" valign=3D"top"><![endif]--><table =
cellpadding=3D"0" cellspacing=3D"0" align=3D"left" class=3D"w" =
role=3D"none" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px;float:left"><tr><td align=3D"center" class=3D"bp" =
style=3D"padding:0;Margin:0;width:177px"><table cellpadding=3D"0" =
cellspacing=3D"0" width=3D"100%" role=3D"presentation" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px"><tr>
<td align=3D"center" style=3D"padding:0;Margin:0;font-size:0px"><a =
target=3D"_blank" =
href=3D"https://eot.investmentoracle.co.uk/f/a/EQV6QwvSfc8m6Db_kp-qow~~/A=
AAHURA~/tCobR5y_rYswfQJP3W9QN4So9krNlVs4TA-Chl_0ExzkyuiK_aQkrPmDwNsrs3du2=
kxgeiJg68ixKpCKeQDbrphn2y6QlbkX5A-tMGMubZFcA9d6UO9hfbWfVV43Tk54lhrGHneRSY=
bIKsQ_H7sxNWA3Br6A4XX8xDTS8pl8yBv-BgR-C8IQLSnZcjEAKReW_YSJbBU_ErWaUu2egUS=
VYh-IlaS66qaDS_2mJkkf4g0~" =
style=3D"mso-line-height-rule:exactly;text-decoration:underline;color:#2C=
B543;font-size:14px"><img =
src=3D"https://hhyqcw.stripocdn.email/content/guids/CABINET_f393bfa185938=
ef1f0ef9f441417a16e7ecf90894ceadd01350ee51fee23eb3f/images/frontier_box_c=
orrect_ratio_ZF5.png" alt=3D"" width=3D"177" =
style=3D"display:block;font-size:14px;border:0;outline:none;text-decorati=
on:none;margin:0" height=3D"132"></a> </td></tr><tr><td align=3D"center" =
valign=3D"top" height=3D"16" class=3D"h-auto" style=3D"padding:10px 0 =
25px;Margin:0"><p =
style=3D"Margin:0;mso-line-height-rule:exactly;font-family:poppins;line-h=
eight:17px;letter-spacing:0;color:#ffffff;font-size:14px"><strong =
style=3D"font-weight:700 !important">10.5=C3=97 Projected Returns =
&nbsp;&nbsp;</strong></p></td></tr></table></td></tr></table> <!--[if =
mso]></td>
<td style=3D"width:20px"></td> <td style=3D"width:175px" =
valign=3D"top"><![endif]--><table cellpadding=3D"0" cellspacing=3D"0" =
align=3D"right" class=3D"x" role=3D"none" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px;float:right"><tr><td align=3D"center" =
style=3D"padding:0;Margin:0;width:175px"><table cellpadding=3D"0" =
cellspacing=3D"0" width=3D"100%" role=3D"presentation" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px"><tr>
<td align=3D"center" style=3D"padding:0;Margin:0;font-size:0px"><a =
target=3D"_blank" =
href=3D"https://eot.investmentoracle.co.uk/f/a/EQV6QwvSfc8m6Db_kp-qow~~/A=
AAHURA~/tCobR5y_rYswfQJP3W9QN4So9krNlVs4TA-Chl_0ExzkyuiK_aQkrPmDwNsrs3du2=
kxgeiJg68ixKpCKeQDbrphn2y6QlbkX5A-tMGMubZFcA9d6UO9hfbWfVV43Tk54lhrGHneRSY=
bIKsQ_H7sxNWA3Br6A4XX8xDTS8pl8yBv-BgR-C8IQLSnZcjEAKReW_YSJbBU_ErWaUu2egUS=
VYh-IlaS66qaDS_2mJkkf4g0~" =
style=3D"mso-line-height-rule:exactly;text-decoration:underline;color:#2C=
B543;font-size:14px"><img =
src=3D"https://hhyqcw.stripocdn.email/content/guids/CABINET_bb89119e98324=
472b76ebb95026f5abd1ca9deaf45af5560d554f946c8168d2d/images/i252_eis_cl20_=
frontier_diagnostic_mar_25_p005_1.png" alt=3D"" width=3D"175" =
class=3D"adapt-img" =
style=3D"display:block;font-size:14px;border:0;outline:none;text-decorati=
on:none;margin:0" height=3D"131"></a> </td></tr><tr><td align=3D"center" =
valign=3D"top" height=3D"16" class=3D"h-auto" style=3D"padding:10px 0 =
25px;Margin:0"><p =
style=3D"Margin:0;mso-line-height-rule:exactly;font-family:poppins;line-h=
eight:17px;letter-spacing:0;color:#ffffff;font-size:14px"><strong =
style=3D"font-weight:700 !important">Exit Targeted Q4 =
2029</strong></p></td></tr></table></td></tr></table>
<!--[if mso]></td></tr></table><![endif]--></td></tr> <tr><td =
align=3D"left" bgcolor=3D"#3d5974" style=3D"padding:0 =
20px;Margin:0;background-color:#3d5974;border-radius:0px 0px =
15px"><table cellpadding=3D"0" cellspacing=3D"0" width=3D"100%" =
role=3D"none" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px"><tr><td align=3D"center" valign=3D"top" =
style=3D"padding:0;Margin:0;width:560px"><table cellpadding=3D"0" =
cellspacing=3D"0" width=3D"100%" role=3D"presentation" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px"><tr>
<td align=3D"center" bgcolor=3D"#3d5974" valign=3D"middle" =
height=3D"168" class=3D"h-auto a" style=3D"padding:0;Margin:0"><p =
class=3D"b" =
style=3D"Margin:0;mso-line-height-rule:exactly;font-family:oswald, =
sans-serif;line-height:42px;letter-spacing:0;color:#a9d1d6;font-size:28px=
"><b style=3D"color:#ffffff">"WE ARE NOT JUST <span =
style=3D"color:#a9d1d6">IMPROVING DIAGNOSTICS</span> - WE ARE<span =
style=3D"color:#a9d1d6"> REWRITING THE TIMELINE</span> OF CANCER =
CARE"</b></p> <p =
style=3D"Margin:0;mso-line-height-rule:exactly;font-family:oswald, =
sans-serif;line-height:42px;letter-spacing:0;color:#a9d1d6;font-size:28px=
"><br/></p><p class=3D"b" =
style=3D"Margin:0;mso-line-height-rule:exactly;font-family:oswald, =
sans-serif;line-height:42px;letter-spacing:0;color:#a9d1d6;font-size:28px=
"><b style=3D"color:#ffffff">Dr. Martin Burow, <span =
style=3D"color:#a9d1d6">CEO</span></b></p></td></tr></table></td></tr></t=
able></td></tr> <tr>
<td align=3D"left" bgcolor=3D"#3d5974" class=3D"bo" =
style=3D"padding:15px 20px 0;Margin:0;background-color:#3d5974"><table =
cellpadding=3D"0" cellspacing=3D"0" width=3D"100%" role=3D"none" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px"><tr><td align=3D"center" valign=3D"top" =
style=3D"padding:0;Margin:0;width:560px"><table cellpadding=3D"0" =
cellspacing=3D"0" width=3D"100%" role=3D"presentation" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px"><tr>
<td align=3D"center" valign=3D"middle" height=3D"77" class=3D"h-auto bn" =
style=3D"Margin:0;padding:10px 40px 15px"><!--[if mso]><a =
href=3D"https://offers.investinform.co.uk/diagnostic-cancer-eis-tax-relie=
f-p-100" data-msys-linkname=3D"1074198b4591757a3565e03fd36ed650" =
target=3D"_blank" hidden> <v:roundrect =
xmlns:v=3D"urn:schemas-microsoft-com:vml" =
xmlns:w=3D"urn:schemas-microsoft-com:office:word" esdevVmlButton =
href=3D"https://offers.investinform.co.uk/diagnostic-cancer-eis-tax-relie=
f-p-100" style=3D"height:54px; v-text-anchor:middle; width:480px" =
arcsize=3D"50%" stroke=3D"f" fillcolor=3D"#a9d1d6"> =
<w:anchorlock></w:anchorlock> <center style=3D'color:#ffffff; =
font-family:Oswald, sans-serif; font-size:20px; font-weight:400; =
line-height:20px; mso-text-raise:1px'>ACCESS THE INVESTMENT =
DETAILS</center> </v:roundrect></a>
<![endif]--><!--[if !mso]><!-- --><span class=3D"bc msohide" =
style=3D"border-style:solid;border-color:#c0ffad;background:#a9d1d6;borde=
r-width:0px;display:block;border-radius:30px;width:auto;mso-hide:all;text=
-align:center !important"><a =
href=3D"https://eot.investmentoracle.co.uk/f/a/EQV6QwvSfc8m6Db_kp-qow~~/A=
AAHURA~/tCobR5y_rYswfQJP3W9QN4So9krNlVs4TA-Chl_0ExzkyuiK_aQkrPmDwNsrs3du2=
kxgeiJg68ixKpCKeQDbrphn2y6QlbkX5A-tMGMubZFcA9d6UO9hfbWfVV43Tk54lhrGHneRSY=
bIKsQ_H7sxNWA3Br6A4XX8xDTS8pl8yBv-BgR-C8IQLSnZcjEAKReW_YSJbBU_ErWaUu2egUS=
VYh-IlaS66qaDS_2mJkkf4g0~" target=3D"_blank" class=3D"e msohide f" =
style=3D"mso-style-priority:100 !important;text-decoration:none =
!important;mso-line-height-rule:exactly;color:#ffffff;font-size:20px;padd=
ing:15px =
5px;display:block;background:#a9d1d6;border-radius:30px;font-family:Oswal=
d, =
sans-serif;font-weight:normal;font-style:normal;line-height:24px;width:au=
to;text-align:center;letter-spacing:0;mso-padding-alt:0;mso-border-alt:10=
px solid #a9d1d6;mso-hide:all">ACCESS THE INVESTMENT DETAILS</a> =
</span><!--<![endif]--></td></tr></table></td></tr><tr>
<td align=3D"center" valign=3D"top" =
style=3D"padding:0;Margin:0;width:560px"><table width=3D"100%" =
cellpadding=3D"0" cellspacing=3D"0" role=3D"presentation" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px"><tr><td align=3D"center" class=3D"bm bq bl bk a" =
style=3D"Margin:0;padding:10px 20px 20px"><p class=3D"b" =
style=3D"Margin:0;mso-line-height-rule:exactly;font-family:oswald, =
sans-serif;line-height:36px;letter-spacing:0;color:#a9d1d6;font-size:30px=
"><b style=3D"color:#ffffff"><span =
style=3D"color:#a9d1d6">&nbsp;INVESTMENT</span> =
HIGHLIGHTS</b></p></td></tr></table></td></tr></table></td></tr> <tr><td =
align=3D"left" bgcolor=3D"#3d5974" style=3D"padding:5px 20px =
0;Margin:0;background-color:#3d5974"><table cellpadding=3D"0" =
cellspacing=3D"0" width=3D"100%" role=3D"none" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px"><tr>
<td align=3D"center" valign=3D"top" =
style=3D"padding:0;Margin:0;width:560px"><table cellpadding=3D"0" =
cellspacing=3D"0" width=3D"100%" role=3D"presentation" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px"><tr><td align=3D"left" class=3D"a" =
style=3D"padding:0 0 15px;Margin:0"><ul style=3D"font-family:arial, =
'helvetica neue', helvetica, sans-serif;padding:0px 0px 0px =
40px;margin-top:15px;margin-bottom:15px"> <li class=3D"c" =
style=3D"color:#ffffff;margin:0px 0px =
15px;font-size:16px;font-family:poppins;line-height:24px"><strong =
style=3D"font-weight:700 !important;font-size:16px">HMRC-approved EIS =
opportunity offering generous tax breaks </strong></li> <li class=3D"c" =
style=3D"color:#ffffff;margin:0px 0px =
15px;font-size:16px;font-family:poppins;line-height:24px"><strong =
style=3D"font-weight:700 !important;font-size:16px">Shares priced at =
=C2=A31.20. Post-money valuation: =C2=A318m</strong></li>=20
<li class=3D"c" style=3D"color:#ffffff;margin:0px 0px =
15px;font-size:16px;font-family:poppins;line-height:24px"><strong =
style=3D"font-weight:700 !important;font-size:16px">Raising =C2=A33m. =
Minimum investment: =C2=A312,000</strong></li> <li class=3D"c" =
style=3D"color:#ffffff;margin:0px 0px =
15px;font-size:16px;line-height:24px;font-family:poppins"><strong =
style=3D"font-weight:700 !important;font-size:16px">ISO 15189-accredited =
laboratory. Operational in UK &amp; Europe</strong></li> <li class=3D"c" =
style=3D"color:#ffffff;margin:0px 0px =
15px;font-size:16px;line-height:24px;font-family:poppins"><strong =
style=3D"font-weight:700 !important;font-size:16px">Established =
distribution partnerships across Southeast Asia</strong></li> <li =
class=3D"c" style=3D"color:#ffffff;margin:0px 0px =
15px;font-size:16px;font-family:poppins;line-height:24px"><strong =
style=3D"font-weight:700 !important;font-size:16px">Forecast =
=C2=A361.75m revenue and =C2=A331.5m EBITDA by 2029</strong></li>=20
<li class=3D"c" style=3D"color:#ffffff;margin:0px 0px =
15px;font-size:16px;font-family:poppins;line-height:24px"><strong =
style=3D"font-weight:700 !important;font-size:16px">Planned M&amp;A exit =
Q4 2029. Targeting 10.5x return</strong></li> </ul></td></tr> <tr><td =
align=3D"center" style=3D"Margin:0;padding:20px 20px =
15px;font-size:0"><table border=3D"0" width=3D"80%" height=3D"100%" =
cellpadding=3D"0" cellspacing=3D"0" role=3D"presentation" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px"><tr><td =
style=3D"padding:0;Margin:0;border-bottom:1px solid =
#ffffff;background:unset;height:0px;width:100%;margin:0px"></td></tr></ta=
ble></td></tr><tr>
<td align=3D"center" class=3D"bn" style=3D"Margin:0;padding:10px 20px =
20px"><p =
style=3D"Margin:0;mso-line-height-rule:exactly;font-family:oswald, =
sans-serif;line-height:36px;letter-spacing:0;color:#a9d1d6;font-size:30px=
"><b style=3D"color:#ffffff"><span style=3D"color:#a9d1d6">WHY</span> =
INVEST</b></p></td></tr><tr><td align=3D"left" class=3D"a" =
style=3D"padding:0 30px 15px 0;Margin:0"><ul style=3D"font-family:arial, =
'helvetica neue', helvetica, sans-serif;padding:0px 0px 0px =
40px;margin-top:15px;margin-bottom:15px"> <li =
style=3D"color:#ffffff;margin:0px 0px =
15px;font-size:16px;font-family:poppins;line-height:24px"><strong =
style=3D"font-weight:700 !important;font-size:16px">A =C2=A31.87bn =
European cancer diagnostics market growing at 4.8% =
annually</strong></li>=20
<li class=3D"c" style=3D"color:#ffffff;margin:0px 0px =
15px;font-size:16px;font-family:poppins;line-height:24px"><strong =
style=3D"font-weight:700 !important;font-size:16px">Proprietary CTC =
technology with a clear, scalable path to global clinical =
adoption</strong></li> <li class=3D"c" style=3D"color:#ffffff;margin:0px =
0px 15px;font-size:16px;font-family:poppins;line-height:24px"><strong =
style=3D"font-weight:700 !important;font-size:16px">Already operating in =
a clinical setting - ISO 15189-accredited lab processing real patient =
samples with a 5-day turnaround</strong></li> <li class=3D"c" =
style=3D"color:#ffffff;margin:0px 0px =
15px;font-size:16px;font-family:poppins;line-height:24px"><strong =
style=3D"font-weight:700 !important;font-size:16px">Dual revenue model - =
per-test lab fees plus hardware sales of the Quantum FluoScope device, =
with recurring consumable income</strong></li>=20
<li style=3D"color:#ffffff;margin:0px 0px =
15px;font-size:16px;font-family:poppins;line-height:24px"><strong =
style=3D"font-weight:700 !important;font-size:16px">Debt-free company =
backed by a world-class medical advisory board including former Chief =
Medical Officer of Teva Pharmaceuticals</strong></li> </ul></td></tr> =
<tr>
<td align=3D"center" valign=3D"middle" height=3D"77" class=3D"h-auto bn" =
style=3D"padding:0 40px;Margin:0"><!--[if mso]><a =
href=3D"https://offers.investinform.co.uk/diagnostic-cancer-eis-tax-relie=
f-p-100" data-msys-linkname=3D"1074198b4591757a3565e03fd36ed650" =
target=3D"_blank" hidden> <v:roundrect =
xmlns:v=3D"urn:schemas-microsoft-com:vml" =
xmlns:w=3D"urn:schemas-microsoft-com:office:word" esdevVmlButton =
href=3D"https://offers.investinform.co.uk/diagnostic-cancer-eis-tax-relie=
f-p-100" style=3D"height:54px; v-text-anchor:middle; width:480px" =
arcsize=3D"50%" stroke=3D"f" fillcolor=3D"#a9d1d6"> =
<w:anchorlock></w:anchorlock> <center style=3D'color:#ffffff; =
font-family:Oswald, sans-serif; font-size:20px; font-weight:400; =
line-height:20px; mso-text-raise:1px'>ACCESS THE INVESTMENT =
DETAILS</center> </v:roundrect></a>
<![endif]--><!--[if !mso]><!-- --><span class=3D"bc msohide" =
style=3D"border-style:solid;border-color:#c0ffad;background:#a9d1d6;borde=
r-width:0px;display:block;border-radius:30px;width:auto;mso-hide:all;text=
-align:center !important"><a =
href=3D"https://eot.investmentoracle.co.uk/f/a/EQV6QwvSfc8m6Db_kp-qow~~/A=
AAHURA~/tCobR5y_rYswfQJP3W9QN4So9krNlVs4TA-Chl_0ExzkyuiK_aQkrPmDwNsrs3du2=
kxgeiJg68ixKpCKeQDbrphn2y6QlbkX5A-tMGMubZFcA9d6UO9hfbWfVV43Tk54lhrGHneRSY=
bIKsQ_H7sxNWA3Br6A4XX8xDTS8pl8yBv-BgR-C8IQLSnZcjEAKReW_YSJbBU_ErWaUu2egUS=
VYh-IlaS66qaDS_2mJkkf4g0~" target=3D"_blank" class=3D"e msohide g" =
style=3D"mso-style-priority:100 !important;text-decoration:none =
!important;mso-line-height-rule:exactly;color:#ffffff;font-size:20px;padd=
ing:15px =
5px;display:block;background:#a9d1d6;border-radius:30px;font-family:Oswal=
d, =
sans-serif;font-weight:normal;font-style:normal;line-height:24px;width:au=
to;text-align:center;letter-spacing:0;mso-padding-alt:0;mso-border-alt:10=
px solid #a9d1d6;mso-hide:all">ACCESS THE INVESTMENT DETAILS</a> =
</span><!--<![endif]--></td></tr></table></td></tr></table></td></tr><tr>=

<td align=3D"left" bgcolor=3D"#3d5974" style=3D"padding:20px 20px =
0;Margin:0;background-color:#3d5974"><table cellpadding=3D"0" =
cellspacing=3D"0" width=3D"100%" role=3D"none" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px"><tr><td align=3D"center" valign=3D"top" =
style=3D"padding:0;Margin:0;width:560px"><table cellpadding=3D"0" =
cellspacing=3D"0" width=3D"100%" role=3D"presentation" =
style=3D"mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collap=
se;border-spacing:0px"><tr><td align=3D"left" =
style=3D"padding:0;Margin:0"><p =
style=3D"Margin:0;mso-line-height-rule:exactly;font-family:'work =
sans';line-height:12px;letter-spacing:0;color:#ffffff;font-size:8px"><str=
ong style=3D"font-weight:700 !important">Disclaimer:</strong><br/>
 Any person accessing the email and considering potential investment =
opportunities featured in the email should make their own commercial =
assessment after seeking the advice of an appropriately authorised or =
regulated financial adviser. This email should not be construed as =
advice or a personal recommendation to any prospective investor. =
Investments of this nature carry risks to your capital and can go up or =
down. Past performance is not indicative of future results. This =
opportunity is only suitable for high net worth or self-sophisticated =
investors as defined below. You have an annual income in excess of =
=C2=A3100K. Have net assets in excess of =C2=A3250K (excluding your =
pension funds and assets and your private residence). You have been a =
Director of a company turning over at least =C2=A31 million within the =
last two years. You have made more than one investment in an unlisted =
company in the previous two years. You have been a member of a network =
or syndicate of business angels for at least six months. You have worked =
in the last two years in a professional capacity in the private equity =
sector or in the provision of finance for small and medium =
enterprises.</p>
 =
</td></tr></table></td></tr></table></td></tr></table></td></tr></table><=
/td></tr></table></div>
  =20
                =20
=20
<p> Whistler Close<br>Black Dam<br>Basingstoke<br>Hants<br>RG21 =
3HN<br>United Kingdom<p>
		<p><a =
href=3D"https://eot.investmentoracle.co.uk/f/a/U1VFevpSen03nmkz44y_iQ~~/A=
AAHURA~/XJE85kbjwZPlXQ0_WlWfFa0iCA0qpiSs4VIJsRWTavw2fu4F7xAMjq5ajE2nyJMBB=
SMffAqbPJ5L1MKqmkj42ovD1lF3GAAZ84ze0j2ANoifuBwgh2riXEl7rla2CvqUujGKoWAHss=
QxvP0MuTCPYc76glql75-aWmUdtQ9tx_6GxdK_jcG-4yZtp9Ovfp7TlyP8zCAUCXg8B1cKjcj=
rEMsa2fmoOIjjcgfDx7jGvPicADYp2E-WlZIL51V6Qel8jAARiU3TxV9PhIvTiQ0OHD6k7Vi6=
tTnQf7W5dG7czbRAs4pcoOo8hgXkcdEH1KyKRsibYt87pKckCBvTbhrg4K3mg1QruLejbboHX=
M6N6JqhBDjSMtOs21aBK2Zlv2Cl48nJ78oq_kUY7CVpqfaeNmHLtmqFTYvhWmdOHo-XVwT0FY=
-VTXvMN-cyUg9XE7D4">Unsubscribe</a></p>

		<p><a =
href=3D"https://eot.investmentoracle.co.uk/f/a/mAnvgsM3qE3BdtGnbfJiiw~~/A=
AAHURA~/caIJafCBG2GnLqBpAkWvQE5U-npmEIGPix9EfPbXvUWTZVKPMjN98gDJNePB4V0NH=
Ul_uItKEjONFEjwdOASZIWpLZir90K0eFYR22blI101-iu87BoHiBOMBDD74fMNtFQT-QEHSB=
Oapys_BZOP76rhatK5rEY0IuUCobde9ci9avCrAaliDDg0TH8XPWj_nxshpQSznOj4qA3CKi1=
GKFG2-1mnZzedr5oRc2bfXDcJS4cnAC1ADcX9-GloTFU1rTdfzY7qXiWnhp67VJzI830PoKT-=
7CxBczcAWRiApOyBTdAPAfqEZ8beyggGAquhV33-hnMUMTxFt9L4muX7tEzq_z0o2SDThqivL=
1ruwa4~">Powered by EmailOctopus</a></p>
 =20
 =20
 =20
 =20

<img border=3D"0" width=3D"1" height=3D"1" alt=3D"" =
src=3D"https://eot.investmentoracle.co.uk/q/rkkcaVwSlonIgHypQY3gbQ~~/AAAH=
URA~/OkPbKeVfFQuhd13EhLCcyqDa1HzMPlCqaa-vSn7Jjc0njR7abFYXaZmFCMnU3-ID-XzC=
ULRERR1KtkpgBxZvhw~~">
</body>
</html>

------=_NextPart_000_13C9_01DD1BB6.61041C00--